Technical Analysis for NVH - Novoheart Holdings Inc

Grade Last Price % Change Price Change
grade F 0.395 -12.22% -0.055
NVH closed down 12.22 percent on Wednesday, August 5, 2020, on 69 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical NVH trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -12.22%
Narrow Range Bar Range Contraction -12.22%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -12.22%
Crossed Above 200 DMA Bullish -12.22%
Crossed Above 20 DMA Bullish -12.22%
Narrow Range Bar Range Contraction -12.22%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.
Biotechnology Biology Life Sciences Stem Cells Heart Failure

Is NVH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.72
52 Week Low 0.21
Average Volume 9,017
200-Day Moving Average 0.446
50-Day Moving Average 0.455
20-Day Moving Average 0.410
10-Day Moving Average 0.419
Average True Range 0.026
ADX 20.38
+DI 30.284
-DI 41.662
Chandelier Exit (Long, 3 ATRs ) 0.383
Chandelier Exit (Short, 3 ATRs ) 0.442
Upper Bollinger Band 0.458
Lower Bollinger Band 0.362
Percent B (%b) 0.34
BandWidth 23.220
MACD Line -0.009
MACD Signal Line -0.015
MACD Histogram 0.0058
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.403
Resistance 3 (R3) 0.403 0.402 0.401
Resistance 2 (R2) 0.402 0.400 0.401 0.401
Resistance 1 (R1) 0.398 0.399 0.398 0.398 0.400
Pivot Point 0.397 0.397 0.396 0.396 0.397
Support 1 (S1) 0.393 0.395 0.393 0.393 0.390
Support 2 (S2) 0.392 0.394 0.391 0.389
Support 3 (S3) 0.388 0.392 0.389
Support 4 (S4) 0.388